High risk of cardiovascular diseases after diagnosis of multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 10, 2013, Pages 1336-1340

  Jadidi, Elham ^a   Mohammadi, Mohammad ^a   Moradi, Tahereh ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

atrial fibrillation; cardiovascular disease; epidemiology; ethnicity; flutter; heart failure; immigrants; Multiple sclerosis; myocardial infarction; risk factors; stroke; Sweden

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; SEX DIFFERENCE;

ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; ETHNICITY; FLUTTER; HEART FAILURE; IMMIGRANTS; MULTIPLE SCLEROSIS; MYOCARDIAL INFARCTION; RISK FACTORS; STROKE; SWEDEN;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 84880332391     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513475833     Document Type: Article

References (38)

1. Christiansen CF, Christensen S, Farkas DK, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: A population-based cohort study. Neuroepidemiol. 2010 ; 35: 267-274
2. Fleming ST, Blake RL. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol. 1994 ; 47: 1127-1132
3. Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: A population-based controlled study. Eur J Neurol. 2010 ; 17: 1215-1219
4. Allen NB, Lichtman JH, Cohen HW, et al. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiol. 2008 ; 30: 234-238
5. Voskuhl RR, Gold SM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol. 2012 ; 8: 255-263
6. Yang D, Dzayee DA, Beiki O, de Faire U, Alfredsson L, Moradi T. Incidence and case fatality after day 28 of first time myocardial infarction in Sweden 1987-2008. Eur J Prev Cardiol. 2012 ; 19: 1304-1315
7. Li X, Hemminki K, Sundquist K. Regional, socioeconomic and occupational groups and risk of hospital admission for multiple sclerosis: A cohort study in Sweden. Mult Scler. 2008 ; 14: 522-529
8. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol. 1995 ; 47: 425-448
9. Ahlgren C, Lycke J, Oden A, et al. High risk of MS in Iranian immigrants in Gothenburg, Sweden. Mult Scler. 2010 ; 16: 1079-1082
10. Bostrom I, Callander M, Kurtzke JF, et al. High prevalence of multiple sclerosis in the Swedish county of Varmland. Mult Scler. 2009 ; 15: 1253-1262
11. Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007 ; 91: 537-552
12. Manrique-Garcia E, Sidorchuk A, Hallqvist J, et al. Socioeconomic position and incidence of acute myocardial infarction: A meta-analysis. J Epidemiol Community Health. 2011 ; 65: 301-309
13. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 ; 117: 25-146
14. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. BMC Public Health. 2011 ; 11: 450
15. Johannesson I New possibilities and better quality. Örebro: Statistics Sweden ; 2002 :
16. Statistics - Health and Medical Care of the National Board of Health and Welfare: Official statistics of Sweden, Dodsorsaker 2008 (Causes of death 2008) Stockholm, Sweden: ; 2010
17. Quesnel S, Feinstein A. Multiple sclerosis and alcohol: A study of problem drinking. Mult Scler. 2004 ; 10: 197-201
18. Slawta JN, Wilcox AR, McCubbin JA, et al. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil. 2003 ; 84: 1823-1830
19. Nortvedt MW, Riise T, Maeland JG. Multiple sclerosis and lifestyle factors: The Hordaland Health Study. Neurol Sci. 2005 ; 26: 334-339
20. Feinstein A. Multiple sclerosis and depression. Mult Scler. 2011 ; 17: 1276-1281
21. Bombardier CH, Blake KD, Ehde DM, et al. Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler. 2004 ; 10: 35-40
22. Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008 ; 127: 89-97
23. Ramsaransing GS, Fokkema MR, Teelken A, et al. Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2006 ; 77: 189-192
24. Aksungar FB, Topkaya AE, Yildiz Z, et al. Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci. 2008 ; 15: 393-397
25. Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A. J Neuroinflammation. 2008 ; 5: 27
26. Minagar A, Jy W, Jimenez JJ, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 2001 ; 56: 1319-1324
27. Acevedo AR, Nava C, Arriada N, et al. Cardiovascular dysfunction in multiple sclerosis. Acta Neurol Scand. 2000 ; 101: 85-88
28. Fjeldstad C, Frederiksen C, Fjeldstad AS, et al. Arterial compliance in multiple sclerosis: A pilot study. Angiology. 2010 ; 61: 31-36
29. Speciale L, Sarasella M, Ruzzante S, et al. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol. 2000 ; 6: S62-66
30. Toncev G, Milicic B, Toncev S, et al. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol. 2002 ; 9: 221-226
31. Amorini AM, Petzold A, Tavazzi B, et al. Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clin Biochem. 2009 ; 42: 1001-1006
32. Rentzos M, Nikolaou C, Anagnostouli M, et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg. 2006 ; 108: 527-531
33. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004 ; 141: 764-770
34. Murray TJ. The cardiac effects of mitoxantrone: Do the benefits in multiple sclerosis outweigh the risks?. Expert Opin Drug Saf. 2006 ; 5: 265-274
35. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain. 2004 ; 127: 844-850
36. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: Results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry. 1998 ; 65: 56-59
37. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013 ; 380: 2095-2128
38. Christensen S, Farkas DK, Pedersen L, et al. Multiple sclerosis and risk of venous thromboembolism: A population-based cohort study. Neuroepidemiol. 2012 ; 38: 76-83